Advertising and promotion of prescription drugs, including direct-to-consumer, direct-to-patient, and professional marketing.
October 28, 2009
By:Benjamin Curtis
Google opened up a whole new era of social media when it released Sidewiki - a tool that allows anyone to comment on any Web site. Now pharma has a new battle to fight.
 |
October 28, 2009
By:Andrew Sheivachman
Sure, prescription information for Sanofi-Aventis's Uroxatral appears on the back of the tent card, but how can consumer?s see it if it's mounted to a pharmacy wall?
|
October 1, 2009
By:Peter H. Nalen
How a small competitor benefited from the use of interactive marketing.
|
October 1, 2009
Executives should embrace design to discover new markets and find new ways to server customers.
|
September 30, 2009
By:George Koroneos, Online Content & News Editor
Illegal online pharmacies are on the rise, brandjacking dozens of big name pharmaceuticals and netting almost $11 billion in sales this year alone. With consumers on the hunt for affordable meds, the trend is only going to get worse.
|
September 1, 2009
Close the loop between the pros and the consumers by integrating patient-physician communications into pharma brand planning.
|
September 1, 2009
With the emergence of user-generated content, marketers have to keep up on the buzz around their brands and categories on the Web.
|
September 1, 2009
The prescription for better pharma marketing: Gain understanding of your physician-customers by leveraging key analytical insights.
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?
Super Reps book trilogy by Dr. Lou Sawaya MD, MBA
Don't miss this Podcast series commemorating the 20th anniversary of HBA's Woman of the Year Award with interviews spanning two decades of change makers.
Conducting clinical trials in emerging regions can give you the edge. Five Quintiles experts share their insights into navigating the global regulatory landscape.